Prev Arrow Stocks

SNDL Inc. ($SNDL) Stock Forecast: Up 5.5% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is SNDL Inc.?

Sundial Growers (SNDL) is a Canadian company in the liquor and cannabis retail sector. After a recent 18% stock price drop, analysts predict a potential upside of 245% to $4.70 from the current $1.36 price.

Why is SNDL Inc. going up?

SNDL stock is up 5.5% on Apr 14, 2026 20:00

  • Analysts are encouraged by SNDL's cost-cutting measures above C$20M, upcoming store approvals in Ontario, continued international cannabis expansion, and possible advantages from U.S. cannabis policy changes.
  • SNDL's robust financial position, with $60 million in net cash and a low price-to-book ratio of 0.447, are factors supporting the optimistic outlook.
  • Investor confidence in SNDL's strategies and growth opportunities in the cannabis market are fueling a positive stock movement.

SNDL Price Chart

SNDL Technical Analysis

SNDL News

245% Upside Potential for Sundial Growers (SNDL) After 18% YTD Slide

Sundial Growers (SNDL) stock, despite an 18% year-to-date decline, shows a potential 245% upside as analysts target $4.70 against its current $1.36. The company, Canada's largest private-sector liquor and cannabis retailer, holds a strong balance sheet with over $60 million in net cash and trades at a price-to-book ratio of 0.447. Its recovery hinges on a C$20M+ cost-reduction restructuring, unlocking 27 pending Ontario store approvals, sustained international cannabis growth, and potential benefits from U.S. cannabis rescheduling.

https://247wallst.com/investing/2026/04/10/245-upside-potential-for-sundial-growers-sndl-after-18-ytd-slide/

0 News Article Image 245% Upside Potential for Sundial Growers (SNDL) After 18% YTD Slide

SNDL Inc. Price History

19.11.2025 - SNDL Stock was down 13.4%

  • SNDL witnessed a significant downward trend following information about a proposed securities sale and insider Form 144 filings, leading to concerns regarding future valuation and stock price pressure.
  • Despite the positive outcomes of renewing its share repurchase program and the potential rescheduling of US cannabis, SNDL encountered notable market fluctuations due to investor uncertainties surrounding operational inefficiencies and reported net losses in Q3 2025.
  • The market's reaction may be linked to several factors, including the company's strategic decisions like revising acquisition agreements for cannabis retail stores and the broader impacts of shifts in US policies on the cannabis sector.

10.02.2026 - SNDL Stock was up 5.7%

  • The bullish movement in SNDL stock could be attributed to the positive market sentiment ahead of the company's projected earnings release for Q4 2025.
  • Analysts' expectations of earnings per share of $0.01 and revenue of $257.9740 million might have instilled confidence in investors, leading to increased buying activity.
  • The "Hold" rating from analysts with an average target price of $4.50 could have also contributed to the bullish momentum as investors anticipate potential growth opportunities for the company.

20.01.2026 - SNDL Stock was up 5.6%

  • SNDL's announcement of releasing its Q4 and full-year 2025 financial results on March 12 seems to have generated positive investor sentiment.
  • Investors are likely optimistic about the company's performance and future growth plans, leading to increased buying activity.
  • Despite facing challenges in the Canadian cannabis market and lacking direct U.S. operations, SNDL's consistent growth in the cannabis business and positive free cash flow are attracting investor attention.
  • The upcoming financial results release may provide clarity on SNDL's profitability and potential, contributing to the bullish market movement.

20.01.2026 - SNDL Stock was up 5.9%

  • The bullish movement in SNDL stock today could be attributed to anticipation and optimism surrounding the upcoming release of its financial results.
  • Investors may be encouraged by the company's consistent growth in its cannabis business, despite facing challenges such as intense competition in the Canadian market and the lack of direct U.S. operations.
  • The positive free cash flow and expanding retail footprint in the cannabis sector might have instilled confidence in investors, leading to the bullish trend.
  • SNDL's ability to navigate through competitive pressures and demonstrate strong cannabis sales could be seen as a promising sign for those interested in the Canadian cannabis market.

16.02.2026 - SNDL Stock was down 5.2%

  • SNDL's stock showed bearish movement recently, despite strong Q4 earnings and record-breaking financial performance in 2025.
  • The market's reaction may be linked to concerns about challenges in the cannabis sector and the absence of significant catalysts for immediate improvement.
  • Investors could be wary of SNDL's dependence on U.S. cannabis rescheduling and the removal of the 280E tax for substantial upside potential, despite positive financial results and strategic expansions.
  • The stock's movement may be influenced by general market trends, shifts in investor sentiment, or profit-taking actions following previous gains.

19.02.2026 - SNDL Stock was down 5.3%

  • SNDL stock experienced a strong bearish movement despite positive news of revenue growth and improved earnings in the fourth quarter.
  • Analysts' cautious outlook and 'Hold' rating, coupled with sector uncertainty, likely contributed to the downward pressure on SNDL stock.
  • The stock's performance appears to be heavily reliant on regulatory developments in the U.S. cannabis market, with potential catalysts for an upgrade hinging on factors like cannabis rescheduling and tax reforms.
  • SNDL's international sales growth and expansion plans may offer long-term potential, but near-term market sentiment seems to be driven by sector-wide challenges and analyst recommendations.

14.03.2026 - SNDL Stock was up 5.5%

  • Analysts are encouraged by SNDL's cost-cutting measures above C$20M, upcoming store approvals in Ontario, continued international cannabis expansion, and possible advantages from U.S. cannabis policy changes.
  • SNDL's robust financial position, with $60 million in net cash and a low price-to-book ratio of 0.447, are factors supporting the optimistic outlook.
  • Investor confidence in SNDL's strategies and growth opportunities in the cannabis market are fueling a positive stock movement.

20.02.2026 - SNDL Stock was down 5.8%

  • Even though SNDL reported robust year-over-year revenue growth and enhanced earnings, its stock price decreased, possibly due to investors selling off after a previous increase.
  • Analysts upholding a 'Hold' rating on the stock in light of sector uncertainties may have prompted investor wariness and increased selling activity.
  • Without clear triggers for a stock upgrade and ongoing sector difficulties, investor confidence could have waned, leading to the bearish market performance.
  • Differing analyst perspectives, from pessimistic forecasts to strong buy endorsements, might have amplified uncertainties surrounding SNDL stock, influencing today's downward trend.

23.11.2025 - SNDL Stock was down 5.1%

  • SNDL's stock price dropped by over 13% following an amended agreement for the acquisition of cannabis retail stores from 1CM Inc. This news likely raised concerns among investors about the company's growth prospects and financial health, leading to the bearish market movement.
  • Despite President Trump signing an executive order to reschedule marijuana to Schedule III and expand access to CBD products, SNDL's stock still experienced a downturn initially. This could be due to uncertainties surrounding the implications of the policy change on SNDL's specific operations and financial performance.
  • The 12.3% increase in SNDL's stock price after renewing its share repurchase program and amid hopes of US cannabis rescheduling indicates investor optimism. However, the need for SNDL to demonstrate consistent free cash flow and effective investment management remains a key consideration for investors amidst the evolving regulatory landscape.

16.00.2026 - SNDL Stock was up 0.9%

  • Despite recent negativity and a 25% drop over the past month, SNDL's stock showed a strong uptrend today.
  • The company's low price-to-sales (P/S) ratio of 0.6x, in contrast to the industry's average of 4.5x, indicates investor worries regarding revenue growth.
  • Analysts foresee a modest 3.0% yearly growth for SNDL in the next three years, a sharp contrast to the industry's average of 32%, adding to the prevailing bearish sentiment.
  • Today's positive stock movement might be due to short-term market changes, speculative trading, or potential positive developments that momentarily influenced investor attitudes.

13.02.2026 - SNDL Stock was down 5.6%

  • SNDL reported record annual revenue, expanding gross margins, and a debt-free balance sheet with significant cash reserves, despite which the stock faced a bearish movement.
  • The slight dip in Q4 net revenue, possibly influenced by a broader market weakness in liquor and cannabis retail, could have contributed to the negative trend.
  • Market uncertainties, particularly in U.S. assets, might have impacted investor sentiment, despite SNDL's focus on efficiency, strategic acquisitions, and disciplined capital allocation.
  • The market's reaction to industry challenges and uncertainties may have overshadowed SNDL's positive financial performance and strategic initiatives.

10.03.2026 - SNDL Stock was up 5.1%

  • Positive financial and operational results for both the fourth quarter and the full year of 2025 were reported by SNDL Inc. (SNDL), demonstrating solid performance and growth prospects.
  • Examination of SNDL's financials, covering revenue distribution and profit margins, revealed its strong competitive stance in the industry, potentially attracting more investors.
  • The market responded favorably to SNDL's impressive financial performance and market position, leading to the bullish activity in the stock, with investors viewing the company as an appealing investment opportunity in the Pharmaceuticals sector.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.